Intuitive Surgical, Inc. $ISRG Shares Sold by BDF Gestion

BDF Gestion lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,963 shares of the medical equipment provider’s stock after selling 1,131 shares during the quarter. Intuitive Surgical accounts for about 1.2% of BDF Gestion’s holdings, making the stock its 11th biggest position. BDF Gestion’s holdings in Intuitive Surgical were worth $9,607,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of ISRG. SteelPeak Wealth LLC raised its position in Intuitive Surgical by 28.7% in the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock worth $18,781,000 after acquiring an additional 9,364 shares in the last quarter. Atlantic Union Bankshares Corp boosted its position in shares of Intuitive Surgical by 19.3% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock worth $10,179,000 after purchasing an additional 3,676 shares in the last quarter. World Investment Advisors boosted its position in shares of Intuitive Surgical by 238.3% during the 3rd quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock worth $2,415,000 after purchasing an additional 3,803 shares in the last quarter. E. Ohman J or Asset Management AB grew its stake in shares of Intuitive Surgical by 4.1% during the 3rd quarter. E. Ohman J or Asset Management AB now owns 28,306 shares of the medical equipment provider’s stock worth $12,659,000 after purchasing an additional 1,123 shares during the period. Finally, Valley Wealth Managers Inc. increased its holdings in shares of Intuitive Surgical by 52.7% in the 3rd quarter. Valley Wealth Managers Inc. now owns 4,084 shares of the medical equipment provider’s stock valued at $1,826,000 after purchasing an additional 1,409 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Up 0.0%

Shares of NASDAQ ISRG opened at $478.04 on Tuesday. The stock has a market cap of $169.77 billion, a price-to-earnings ratio of 60.59, a PEG ratio of 3.69 and a beta of 1.66. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $603.88. The company’s 50-day moving average price is $500.94 and its 200 day moving average price is $513.62.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same period last year, the firm posted $2.21 EPS. The firm’s revenue for the quarter was up 18.8% on a year-over-year basis. As a group, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Mark Brosius sold 2,362 shares of the company’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $498.68, for a total value of $1,177,882.16. Following the sale, the senior vice president owned 3,554 shares of the company’s stock, valued at approximately $1,772,308.72. This represents a 39.93% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Fredrik Widman sold 133 shares of the stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the sale, the vice president owned 660 shares in the company, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 32,943 shares of company stock worth $17,279,568. 0.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several analysts recently commented on ISRG shares. Piper Sandler reiterated an “overweight” rating and issued a $620.00 price objective (up from $610.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Robert W. Baird dropped their target price on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a report on Friday, January 23rd. The Goldman Sachs Group reiterated a “buy” rating and set a $714.00 price target on shares of Intuitive Surgical in a research report on Friday, January 9th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $614.95.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.